An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Cybin to Present at the Jefferies London Healthcare Conference
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Cybin, a biopharmaceutical company focused on advancing Psychedelics to Therapeutics, announced that CEO Doug Drysdale will present at the Jefferies London Healthcare Conference from November 18-19, 2021. The presentation will be available on demand starting November 18 at 8:00 AM GMT until November 19 at 5:00 PM GMT. Investors can access the webcast through Cybin's website. Founded in 2019 and headquartered in Canada, Cybin collaborates with leading partners to develop therapeutics for mental health issues.
Positive
None.
Negative
None.
TORONTO--(BUSINESS WIRE)--
Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (“Cybin” or the “Company”), a biopharmaceutical company focused on progressing “Psychedelics to TherapeuticsTM” is pleased to announce that Doug Drysdale, Cybin’s Chief Executive Officer, will present virtually at the Jefferies London Healthcare Conference being held virtually November 18-19, 2021.
Mr. Drysdale’s presentation will be available on demand beginning on Thursday, November 18, 2021 at 8:00 a.m. GMT/3:00 a.m. ET through Friday, November 19, 2021 at 5:00pm GMT/12:00pm ET. To view the presentation, please click here to access the webcast. The archived webcast will also be available on the Company’s investor relations website on the Events & Presentations page.
About Cybin Cybin is a leading ethical biopharmaceutical company, working with a network of world-class partners and internationally recognized scientists, on a mission to create safe and effective therapeutics for patients to address a multitude of mental health issues. Headquartered in Canada and founded in 2019, Cybin is operational in the United States, United Kingdom and Ireland. The Company is focused on progressing Psychedelics to Therapeutics™ by engineering proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for mental health disorders.
When is Cybin's CEO presenting at the Jefferies London Healthcare Conference?
Doug Drysdale, CEO of Cybin, will present at the Jefferies London Healthcare Conference on November 18-19, 2021.
How can I access Cybin's presentation at the Jefferies London Healthcare Conference?
The presentation by Cybin's CEO will be available on demand starting November 18 at 8:00 AM GMT. You can access it through Cybin's investor relations website.
What is the focus of Cybin Inc.?
Cybin is focused on advancing Psychedelics to Therapeutics for mental health issues.
What is the mission of Cybin?
Cybin's mission is to create safe and effective therapeutics for patients suffering from various mental health disorders.
Where is Cybin headquartered?
Cybin is headquartered in Canada and operates in the United States, the United Kingdom, and Ireland.
